YCBD Total Utang marang Modal cbdMD

Lambang korporat lan logo cbdMD Inc. (YCBD)

cbdMD, Inc. (YCBD) is currently struggling with a liquidity shortage due to declining CBD product sales, necessitating cost reductions. Simultaneously, the business is implementing eco-standards by utilizing recyclable packaging and renewable raw materials. The company's price chart reflects a total debt-to-equity ratio of 0.26. Wellness product manufacturing is concentrated in the US, where the company leverages its recognizable brand and online distribution.

YCBD: Total Utang marang Modal cbdMD Corp 04.07.2022 - 28.10.2026
Produk merek cbdMD

To filter for high-quality assets, investors evaluate the balance between borrowed and equity funds to determine the stability of the financing structure. This metric measures the proportion of total liabilities to equity, which on the GURU.Markets platform, via the debt-to-equity ratio, demonstrates the dependence of cbdMD, Inc. (YCBD) on loans while scaling CBD product sales amid volatile wellness market legislation.

Pesaing wigati

Utang marang Ekuitas Haleon HLN|Utang Agregat marang Ekuitas Kenvue Inc|Verona Pharma Corp (VRNA) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Jyong Bio (MENS)|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|amneal.com - Total Utang marang Modal|Utang marang Ekuitas Perrigo (PRGO)|ALVO: Rasio Kabeh Utang marang Dana Pribadi|LQDA (Liquidia Technologies) - Utang marang Ekuitas|Galapagos Corp (GLPG) - Rasio Total Utang marang Ekuitas|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com (MNKD)|Amphastar Pharmaceuticals, Inc. (AMPH) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PCRX (Pacira Pharmaceuticals)|SPRY: Utang marang Ekuitas|TBPH - Utang marang Modal|Rasio Total Utang marang Ekuitas Aquestive Therapeutics AQST|SCPH - Utang Agregat marang Modal|Total Utang marang Modal tectonictx.com TECX|Tonix Pharma (TNXP) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SXTC (SXT Pharmaceuticals)|Utang marang Modal EPRX|BioHarvest Sciences (BHST) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi invizyne.com (EXOZ)|Oramed Pharmaceuticals Inc. - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Entera Bio Ltd ENTX|HYFT - Total Utang marang Modal|ABVC - Utang marang Ekuitas|Total Utang marang Modal Cumberland Pharmaceuticals|QNTM (quantumbiopharma.com) - Rasio Utang marang Ekuitas|Utang marang Ekuitas FGEN|Rasio Total Utang marang Ekuitas Telomir Pharmaceuticals Inc|Total Utang marang Modal Rani Therapeutics RANI|Rasio Utang marang Ekuitas synergychc.com SNYR|Rasio Total Utang marang Ekuitas Rallybio|Rasio Kabeh Utang marang Dana Pribadi Lexaria Bioscience Corp LEXX|Total Utang marang Modal PULM (Pulmatrix)|PTHL: Koefisien Total Utang marang Modal|Utang marang Ekuitas aptorumgroup.com|Lyra Therapeutics Inc (LYRA) - Rasio Utang marang Ekuitas|Total Utang marang Modal IBO|Rasio Total Utang marang Ekuitas TNF Pharma (TNFA)|PRFX (PainReform) - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal altamiratherapeutics.com CYTO|LIPO: Rasio Total Utang marang Ekuitas|Utang marang Modal OptiNose Corp OPTN|PIRS: Total Utang marang Modal|PROC - Rasio Total Utang marang Ekuitas|Petros Pharmaceuticals, Inc. (PTPI) - Total Utang marang Modal|Qilian International Holding Group (QLI) - Utang marang Ekuitas|Total Utang marang Modal ACELYRIN, Inc. (SLRN)|Rasio Utang marang Ekuitas TFFP